Eftimiadi, Gemma and Eftimiadi, Costantino and Vinai, Piergiuseppe (2020) Studies on the Staphylococcal Protein A as a Pharmacological Treatment for Autoimmune Movement Disorders. In: Recent Progress in Microbiology and Biotechnology Vol. 1. B P International, pp. 129-136. ISBN 978-93-89816-83-9
Full text not available from this repository.Abstract
Staphylococcal protein A (SpA) is a key virulence factor that enables Staphylococcus aureus to evade
host innate and adaptive immune response. The immunomodulatory properties of SpA have led to a
hypothesis that it may have pharmacological applications as a treatment for autoimmune disease.
Clinical trials are underway to test whether ultrapure SpA can be used to treat immune
thrombocytopenia and rheumatoid arthritis. Here, we propose to investigate the potential of
staphylococcal protein A as an innovative drug to manage autoimmune movement disorders.
| Item Type: | Book Section |
|---|---|
| Subjects: | STM Open Academic > Biological Science |
| Depositing User: | Unnamed user with email admin@eprint.stmopenacademic.com |
| Date Deposited: | 06 Nov 2023 04:58 |
| Last Modified: | 06 Nov 2023 04:58 |
| URI: | http://publish.sub7journal.com/id/eprint/1531 |
Actions (login required)
- View Item